Lilly bets $3B+ to add China’s Haisco to growing list of partners in five-program pact

Eli Lilly and the Haisco Pharmaceutical Group have yet to disclose what specific indications they plan to prioritize.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top